As Bolar Pharma launches NeuroAiD
Neurologists across the country have decried the increasing prevalence of stroke in Nigeria, warning that if there is no urgent strategic plan by government and private institutions to halt the progression, it is likely to worsen over the next decade, based on the projections by the World Health Organization (WHO) for lower and middle income countries.
The experts who came from different teaching hospitals in the country, while sharing their different clinical experiences on the treatment of stroke patients, agreed with the WHO prediction, which stated that stroke incidence decreased by 42 per cent in high-income countries in the last four and half decades, while it increased by 100 per cent in lower income countries, where Nigeria belongs.
Desirous to get better and new methods of treating and managing stroke cases, to enhance reduction in mortality and acquired disability, the neurologists converged at the launch of NeuroAiD, a new drug produced by Moleac and marketed by Bolar Pharmaceutical in Nigeria, for quick recovery from stroke.
The NeuroAiD launch, held at the Best Western Hostel Plus, Allen Avenue, Ikeja, on 22 February 2017, was chaired by Professor Yomi Ogun, a professor of Internal Medicine/ Neurology and consultant physician / neurologist at Olabisi Onabanjo University Teaching Hospital (OACHS).